Wednesday, March 20, 2019 9:55:51 AM
PR Newswire
BENTONVILLE, Ark., March 19, 2019
BENTONVILLE, Ark., March 19, 2019 /PRNewswire/ -- New sales statistics show GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) ("Company"), is benefiting from increasing consumer awareness, early in 2019. Sales of GLUCODOWN® at Walmart pharmacies are up 27% for the first seven weeks of 2019 vs. the first seven weeks of 2018. Even more impressive is the 27% sales increase in 2019 is measured against a Walmart price "Rollback" in the same period of 2018 (which began the liquidation of the first generation of GLUCODOWN®). Glucose Health, Inc. expects Walmart sales of GLUCODOWN® to continue to increase for the balance fiscal 2019 and additionally, to expand distribution to new national and/or large regional drug store chains.
Amazon sales of GLUCODOWN®, which launched in the third quarter of 2018, are also achieving impressive results. GLUCODOWN® Raspberry earned the status of an "Amazon No. 1 New Product Release" – and not only for the diabetic iced tea category – but an "Amazon No. 1 New Product Release" for the entire iced tea category encompassing bottled diabetic, diet and regular sugared iced teas. The Company will provide the latest statistics related to online sales performance on Amazon, next Tuesday, March 22.
Growing Amazon sales are being driven in part, by the newly produced GLUCODOWN® TV commercial, "Available on Amazon," now airing on Hallmark Movies & Mysteries and Game Show Network. Viewers of the TV commercial are directed to purchase GLUCODOWN® at a dedicated web domain and storefront (www.amazon.com/glucodown) provided by Amazon for GLUCODOWN®. In order for GLUCODOWN® to qualify for this dedicated web domain and storefront, the Company was required to provide the Amazon Brand Registry with a United States Patent and Trade Office ("USPTO") principal register trademark. Following nearly a year of review, Glucose Health, Inc. was recently awarded the highest level of protection from the USPTO, with registration of the trademark "GLUCODOWN®" on the principal register (Reg. # 5572054).
Glucose Health, Inc. also continues to benefit from its key supplier relationship with Archer Daniels Midland ("ADM"). Last week, Glucose Health, Inc. confirmed the Food and Drug Administration's acceptance of the clinical research prepared by ADM, supporting the efficacy of the soluble dietary fiber in GLUCODOWN®; which included clinical data related to glucose metabolism and digestive health. GLUCODOWN® is the first powdered tea mix ever to be successfully enriched with this FDA recognized1 form of soluble dietary fiber.
About Glucose Health, Inc. (OTC: GLUC)
Manufactured by Glucose Health, Inc. (OTC: "GLUC"), GLUCODOWN® is the premier functional tea beverage in the diabetic nutritional consumer category, which encompasses the more than 100 million Americans estimated to be diabetic or pre-diabetic, by the Centers for Disease Control and Prevention.2 GLUCODOWN® is a unique and compelling functional beverage and the first tea mix enriched with healthy soluble fiber. Glucose Health, Inc. is a publicly-traded company with the ticker symbol (OTC: GLUC). GLUCODOWN® is proudly manufactured in the USA in Arkansas and Minnesota.
1https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm610111.htm
2National Diabetes Statistics Review, 2017; Centers for Disease Control and Prevention, Department of Health and Human Services.
Cision View original content:http://www.prnewswire.com/news-releases/walmart-glucodown-sales-increase-27-ytd-300814451.html
SOURCE Glucose Health, Inc.
Back to News Headlines
Other Financial Information
Recent News & Disclosure Filings
Recent SEC Filings
Pink Current Information
Verified Profile 02/2019
Transfer Agent Verified
DAILY ADVANCERS
NTTHF
+ 11.64 %
NGPHF
+ 11.44 %
VNRR
+ 11.43 %
PHVAF
+ 11.03 %
NTGSF
+ 10.37 %
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Enter your email
SIGN UP
Recent GLUC News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/07/2023 07:58:40 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 06/28/2023 05:23:12 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM